VAN HEEK G JAN 4

What Happened
Jan Van Heek, a non-employee director of Minerva Neurosciences, was granted a derivative award of 50,000 shares on 2026-06-03. The grant shows a $0.00 acquisition price (no cash paid) and is reported as an award/ grant (transaction code A) rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-03; Form 4 filed: 2026-06-05 (timely filing).
• Award amount and price: 50,000 shares; $0.00 per share (derivative award).
• Vesting schedule (footnote F1): vests in four equal quarterly installments (1/4 every three months), with the first 1/4 vesting three months after June 3, 2026 (i.e., ~Sept 3, 2026) and the remainder every three months thereafter, contingent on continued service as a non-employee director.
• Shares owned after the transaction: not specified in the provided filing details.
• Filing type/implication: derivative award (likely RSUs or similar); no immediate sale or cash exercise reported.

Context
This is an award to a director and does not represent an open-market purchase or sale. Because the shares are subject to time-based vesting and require continued board service, they do not immediately increase tradable share count. Awards to directors are common as compensation and are informational rather than a direct bullish or bearish trading signal.